# Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)

> **NCT04010955** · — · ACTIVE_NOT_RECRUITING · sponsor: **Asan Medical Center** · enrollment: 1200 (estimated)

## Conditions studied

- Acute Ischemic Stroke
- Atrial Fibrillation
- Extracranial Atherosclerosis
- Intracranial Atherosclerosis
- Coronary Artery Atherosclerosis
- Peripheral Artery Stenosis
- Anticoagulant
- Antiplatelet

## Interventions

- **DRUG:** Edoxaban Monotherapy

## Key facts

- **NCT ID:** NCT04010955
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-10-08
- **Primary completion:** 2025-06-27
- **Final completion:** 2026-06-27
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2025-07-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04010955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04010955, "Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04010955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*